Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     

  • Bitcoin GBP

    50,401.41
    -1,068.04 (-2.08%)
     

  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA

Pactum AS, a closely related party to the primary insider and board member Espen W. Marcussen in Vistin Pharma ASA, has on 29 October 2021 sold 3,519,733 shares in Vistin Pharma ASA at NOK 19.50 per share to its wholly-owned subsidiary Pactum Vekst AS in connection with an internal reorganization of Pactum AS. Pactum Vekst AS is also a closely related party to the primary insider and board member Espen W. Marcussen in Vistin Pharma ASA.

Please refer to the attached notifications of trading for further details.

Attachments